Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Blood Donation for the Development and Optimisation of the Second Generation Microvisk International Normalized Ratio (INR) Testing System for the Measurement of Prothrombin Time (PT)/INR in Patients on Warfarin Therapy.

NCT02355730 is registered in ClinicalTrials.gov with Microvisk Technologies Ltd as lead sponsor.

NCT NCT02355730
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02355730 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Blood Donation for the Development and Optimisation of the Second Generation Microvisk International Normalized Ratio (INR) Testing System for the Measurement of Prothrombin Time (PT)/INR in Patients on Warfarin Therapy.
Lead sponsor
Microvisk Technologies Ltd
Phase
Not applicable
Overall status
Unknown status
Start date
May 31, 2014
Completion date
June 30, 2016
Enrollment
1,560 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, deep vein thrombosis, pulmonary embolism